FloatVerifyFloatVerify
← All articles

Warrants and Dilution: How They Impact Your Shares

Direct answer: Warrants are securities that grant the right to buy new shares at a predetermined price (the exercise price). When exercised, they create additional shares, mechanically diluting existing shareholders' ownership stake and earnings per share. This dilution is particularly critical for small-caps, where a high volume of warrants can double the share count and cut per-share value in half.

What Is a Warrant?

A warrant (or stock purchase warrant) is a financial instrument issued by a company. It gives the holder the right, but not the obligation, to buy a new common share at a predetermined price (the exercise price) during a defined period.

Unlike exchange-traded options—which are contracts between investors—warrants are issued directly by the company. When a warrant is exercised, the company issues a new share and collects the exercise price. This share creation is the source of dilution.

Warrants appear frequently in three contexts:

  • SPAC IPOs (Special Purpose Acquisition Company): each unit sold typically includes one common share plus a warrant fraction (often 1/2 or 1/3 warrant).
  • Private placements (PIPEs): to sweeten the deal, companies add coverage warrants.
  • Distressed fundraising: a struggling company may offer warrants to offset a low issuance price.

Warrants carry a distinct ticker symbol on US markets. Common suffixes include .W, .WS, or .WT. They trade separately from the common stock and have their own market price, which reflects the probability and profitability of future exercise.

The Dilution Mechanism: Creating New Shares

Dilution occurs at the moment of warrant exercise. Here's the three-step mechanism:

  1. Before exercise: the company has, say, 10 million shares outstanding. Warrants exist but aren't yet shares.
  2. Exercise: a warrant holder pays the exercise price (for example, $11.50 per share) and requests issuance of a new share.
  3. After exercise: the company issues a new share. Total shares rise to 10 million plus one. Each existing shareholder now owns a slightly smaller piece of the company.

If 2 million warrants are exercised, total shares jump from 10 million to 12 million. The dilution is 16.7%: each share now represents 1/12th of the company instead of 1/10th.

Impact on Earnings Per Share (EPS)

Dilution directly affects EPS (net income divided by share count). If the company earns $5 million:

  • Before exercise: EPS = $5M / 10M shares = $0.50/share
  • After exercise: EPS = $5M / 12M shares = $0.42/share

EPS drops 16%, even though net income stays the same. This mechanic pressures the share price: at constant valuation, price per share must adjust downward.

Where to Find the Information in SEC Filings

Outstanding warrants and their exercise terms are detailed in several SEC forms:

FormWarrant Content
10-KAnnual report. "Stockholders' Equity" section or financial statement note "Warrants": count outstanding, exercise price, expiration date, exercise conditions.
10-QQuarterly report. Updates on warrants exercised or redeemed since the last 10-K.
S-1IPO registration statement (notably SPACs). Details public and private warrants issued, warrant/unit ratio, redemption clauses.
424BFinal prospectus. Confirms final warrant terms offered.
8-KCurrent report for significant events. Reports one-off warrant issuances (private placement, emergency fundraising). Item 3.02 (issuance of unregistered securities) or 8.01 (other events).

In a 10-K filing, look for the section "Note X — Stockholders' Equity" or "Warrants and Rights". You'll find a table like:

  • Public warrants outstanding: X million
  • Private warrants outstanding: Y million
  • Exercise price: $11.50 per share
  • Expiration date: 5 years after IPO
  • Redemption conditions: company may redeem warrants at $0.01 if stock closes above $18 for 20 consecutive days

This information is dated ("as of December 31, 2025"). Any subsequent exercise renders the figure obsolete.

Public vs. Private Warrants

Warrants split into two categories with distinct dilutive impacts:

Public Warrants

Trade on exchanges (distinct ticker). Issued in public offerings (SPAC units, IPOs). Transparent: outstanding count is public and updated. Exercised individually by holders, creating staggered dilution over time.

Private Warrants (Placement Warrants)

Unlisted, issued in private placements (PIPEs, private placement). Often held by sponsors, founders, or institutional investors. Subject to lock-up periods (resale restrictions). Exercised in blocks, creating sudden, massive dilution when lock-ups expire.

Private warrants attract particular scrutiny in small-caps born from SPACs. Sponsors often receive millions of private warrants at very low exercise prices (sometimes $0.01), generating asymmetric dilution that benefits insiders.

Why It's Critical for Small-Caps

Small-caps (market cap under $2 billion) face disproportionate exposure to warrant dilution. Three reasons:

Reduced float. An issuance of 5 million warrants represents 50% dilution for a company with 10 million shares outstanding, but only 5% for a company with 100 million shares. The relative impact is 10 times greater.

Frequent financing. Small-caps often raise funds through private placements, each accompanied by coverage warrants (50-100% coverage). A company raising $10 million by issuing 1 million shares at $10 may add 1 million additional warrants, doubling potential dilution.

Price volatility. A warrant with an $11.50 exercise price is "out of the money" if the stock trades at $8. But it becomes "in the money" as soon as the stock hits $12. On a small-cap that gaps up, a 50% move in a few weeks can trigger mass exercise of millions of warrants, unleashing unexpected dilution.

The Cascade Dilution Trap

When a small-cap announces good news (contract, FDA approval), the stock rises. Warrants become exercisable. Exercise creates new shares, increasing supply. If demand doesn't keep pace, the price falls, triggering more selling. This self-reinforcing mechanism is common in small-cap biotech and post-merger SPACs.

The FloatVerify Angle: Sourced and Dated Data

FloatVerify displays the number of outstanding warrants as of the last SEC update, with the exact source (Form 10-Q dated August 15, 2026, page 18). When two sources diverge—for example, a 10-Q dated June 30 showing 8 million warrants, and an 8-K dated July 12 reporting a redemption of 2 million—FloatVerify displays both figures in amber ("source split") instead of picking one arbitrarily.

This approach is crucial for warrants. A figure "as of June 30" can be obsolete by July 1 if mass exercise occurs. FloatVerify dates every data point and flags when an update is missing or divergent, letting users judge information freshness.

Unlike aggregators that show a "total shares" without distinguishing float from unexercised warrants, FloatVerify separates:

  • Current float (shares already issued and freely tradable)
  • Outstanding warrants (potential future dilution)
  • Other dilutive securities (options, RSUs, convertible bonds)

Each line carries its SEC source and date. No single falsely certain figure.

Recap

PointTakeaway
WarrantRight to buy a new share at a fixed price during a defined period, issued by the company itself.
DilutionExercise creates a new share, reducing each existing shareholder's ownership stake and EPS.
Where to LookForms 10-K (annual), 10-Q (quarterly), S-1/424B (IPO), 8-K (events), "Stockholders' Equity" section or notes.
Small-Cap ImpactReduced float + frequent financing = very high relative dilution. A warrants/float ratio above 20% is a red flag.
Public vs. PrivatePublic: tradable, staggered dilution. Private: unlisted, sudden massive dilution, often at very low exercise prices.
Dating CriticalA warrant exercised yesterday makes today's figure obsolete. Always check the SEC source date.

FAQ

How do warrants dilute existing shares?

When a warrant is exercised, the company issues a new share in exchange for the exercise price. This creation increases the total shares outstanding, mechanically reducing each existing shareholder's ownership percentage and earnings per share. The dilution is more severe when the number of warrants exercised is high relative to the initial float.

Where do I find outstanding warrants in SEC filings?

Outstanding warrants appear in Form 10-K (annual report) and 10-Q (quarterly report), in the "Capital Stock" or "Equity" section of the financial statement notes. Form S-1 (IPO registration) and 424B (final prospectus) detail warrants issued during a SPAC or public offering. Form 8-K reports warrant issuances tied to specific events.

What's the difference between public and private warrants?

Public warrants trade on exchanges (distinct ticker symbol, often .W or .WS) and are exercised by individual holders. Private warrants, issued in private placements (PIPEs), don't trade publicly and often have lock-up periods. Both dilute shares upon exercise, but public warrants create more visible and predictable dilution the market can anticipate.

Do warrants count in the float calculation?

No, outstanding warrants aren't included in the float until exercised. The float measures shares already issued and freely tradable. However, exercised warrants generate new shares that immediately enter the float calculation if they aren't subject to restrictions. That's why FloatVerify dates every figure: a float "as of October 15" can become obsolete the next day if warrants are exercised en masse.

How do I anticipate potential warrant dilution?

Calculate total outstanding warrants (public + private) divided by current float: a ratio above 20% signals significant potential dilution. Check the exercise price in SEC filings—the lower it is relative to the current share price, the more likely exercise becomes. Finally, review the expiration date: a warrant nearing expiration and "in the money" will almost certainly be exercised.

Sources

  • SEC EDGAR Database — Access to Forms 10-K, 10-Q, S-1, 424B, 8-K for all listed companies
  • SEC Forms: 10-K (annual report), 10-Q (quarterly report), S-1 (IPO registration), 424B (final prospectus), 8-K (current report)
  • SEC Regulation S-X, Article 5-02(29) — Presentation of warrants in financial statements
  • Financial Accounting Standards Board (FASB) — ASC 815-40, warrant accounting
  • SEC Investor Publications — Guides on dilutive securities and SPACs

See the float, sourced and dated, on FloatVerify.


FloatVerify shows the float, dilution and cash burn of US small-caps, every number sourced and dated — and surfaces divergences between sources ("source split") instead of one falsely certain figure.

Disclaimer: FloatVerify is a data tool, not an investment advisory service. Nothing here is a recommendation to buy or sell. Data, not advice.

The float, sourced. The doubt, shown.

FloatVerify shows the float, dilution and cash burn of US small-caps — every number linked to its SEC filing.

Create account